Fischer, Thomas <br/><br/>
[Results up to now of administration of STI-571 (Glivec) in recurrence after allogenic and autologous stem cell transplantation in chronic myeloid leukemia].  [electronic resource] 

 -  Medizinische Klinik (Munich, Germany : 1983)  Jan 2002 
 - 22-7 p.  digital 
<br/><br/> Publication Type: English Abstract; Journal Article 
<br/><br/><label>ISSN: </label>0723-5003 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Antineoplastic Agents--adverse effects<br/>Benzamides<br/>Child<br/>Clinical Trials as Topic<br/>Enzyme Inhibitors--adverse effects<br/>Female<br/>Hematopoietic Stem Cell Transplantation<br/>Humans<br/>Imatinib Mesylate<br/>Leukemia, Myelogenous, Chronic, BCR-ABL Positive--drug therapy<br/>Male<br/>Middle Aged<br/>Piperazines--adverse effects<br/>Pyrimidines--adverse effects<br/>Remission Induction<br/>Treatment Outcome